Filed: 5/15/2023ACC: 0001892688-23-000053
📋 What this filing means
DARWIN GLOBAL MANAGEMENT, LTD. filed this quarterly 13F‑HR report disclosing 4 equity positions with a total reported market value of $365.62M. This filing provides a transparent view of the manager's long equity holdings as of the quarter end.
4
Positions
$365.62M
Total AUM (reported)
22.07M
Total Shares
Allocation by class
COM$158.53M43.4%
SPONSORED ADR$106.26M29.1%
SPONSORED ADS$100.84M27.6%
Portfolio Concentration
Top 3$364.28M99.6%
4–10$1.34M0.4%
Top 3 weight
99.6%
Top 10 weight
100.0%
Voting Authority Distribution
Total shares with voting rights: 22.07M
Sole
Full voting authority
22.07M
shares
% of voting shares100.0%
Shared
Joint voting authority
0.00
shares
% of voting shares0.0%
None
No voting authority
0.00
shares
% of voting shares0.0%
Investment Discretion (by position count)
Sole4
Shared0
Other0
Dominant voting typeSole · 100.0% of voting shares
Institutional Holdings4
Rows:
TG THERAPEUTICS INC
SOLEShares10.45M
TypeSH
Market value$157.19M
42.99%
Sole
10.45M
Shared
0.00
None
0.00
ARGENX SE
SOLEShares285.20K
TypeSH
Market value$106.26M
29.06%
Sole
285.20K
Shared
0.00
None
0.00
AMBRX BIOPHARMA INC
SOLEShares11.30M
TypeSH
Market value$100.84M
27.58%
Sole
11.30M
Shared
0.00
None
0.00
KEROS THERAPEUTICS INC
SOLEShares31.39K
TypeSH
Market value$1.34M
0.37%
Sole
31.39K
Shared
0.00
None
0.00
| Issuer | Class | Shares | Type | Value / Portfolio % | Voting — Sole | Shared | None |
|---|---|---|---|---|---|---|---|
TG THERAPEUTICS INCSOLE | COM | 10.45M | SH | $157.19M 42.99% | 10.45M | 0.00 | 0.00 |
ARGENX SESOLE | SPONSORED ADR | 285.20K | SH | $106.26M 29.06% | 285.20K | 0.00 | 0.00 |
AMBRX BIOPHARMA INCSOLE | SPONSORED ADS | 11.30M | SH | $100.84M 27.58% | 11.30M | 0.00 | 0.00 |
KEROS THERAPEUTICS INCSOLE | COM | 31.39K | SH | $1.34M 0.37% | 31.39K | 0.00 | 0.00 |